Ovidiu Horea Bedreag, Alexandru Florin Rogobete, Dorel Sandesc, Carmen Alina Cradigati, Mirela Sarandan, Radu Nartita, Raluca Dumache, Mihai Mircea Diaconu and Marius Papurica
Neurol Neurosurg . 2011;113(6):459-463.
22. Agnati LF, Genedani S, Rasio G, et al. Studies on homocysteine plasma levels in Alzheimer’s patients. Relevance for neurodegeneration. J Neural Transm . 2005;112:163-169.
23. Genedania S, Rasiob G, Cortellic P, et al. Studies on Homocysteine and Dehydroepiandrosterone Sulphate Plasma Levels in Alzheimer’s Disease Patients and in Parkinson’s Disease Patients. Neurotox Res . 2004;6(4):327-332.
24. Jami M-S, Pal R, Hoedt E, Neubert T, Larsen JP, Møller SG. Proteome analysis reveals roles of L-DOPA in response
Alexandra Lazăr, Anca Meda Georgescu, Alexander Vitin and Leonard Azamfirei
rearrangements. There are other “omes” zones including epigenome, transcriptome, proteome, metabolome though these are less commonly used. These zones contain tremendous information which could be utilised in treating the individual instead of the disease [ 10 ].
Personalised medicine is about using data on multiple scales, and having the ability to create a digital human mapping, with superimposed layers which includes, among other things, social graphs, biosensors, imaging for anatomy description, the characteristics of various “omics” such as genomics, DNA sequencing